Please use this identifier to cite or link to this item: https://doi.org/10.1016/j.mam.2009.12.002
Title: TRAILing death in cancer
Authors: Mellier, G. 
Huang, S. 
Shenoy, K.
Pervaiz, S. 
Keywords: Apoptosis
Chemo-sensitization
Death receptors
Mitochondria
TRAIL
Issue Date: 2010
Source: Mellier, G., Huang, S., Shenoy, K., Pervaiz, S. (2010). TRAILing death in cancer. Molecular Aspects of Medicine 31 (1) : 93-112. ScholarBank@NUS Repository. https://doi.org/10.1016/j.mam.2009.12.002
Abstract: The observation that certain types of cancer express death receptors on their cell surface has triggered heightened interest in exploring the potential of receptor ligation as a novel anti-cancer modality, and since the expression is somewhat restricted to cancer cells the therapeutic implications are very promising. One such death receptor ligand belonging to the tumor necrosis receptor (TNF) superfamily, TNF-related apoptosis-inducing ligand (TRAIL), has been in the limelight as a tumor selective molecule that transmits death signal via ligation to its receptors (TRAIL-R1 and TRAIL-R2 or death receptors 4 and 5; DR4 and DR5). Interestingly, TRAIL-induced apoptosis exhibits hallmarks of extrinsic as well as intrinsic death pathways, and, therefore, is subject to regulation both at the cell surface receptor level as well as more downstream at the post-mitochondrial level. Despite the remarkable selectivity of DR expression on cancer cell surface, development of resistance to TRAIL-induced apoptosis remains a major challenge. Therefore, unraveling the cellular and molecular mechanisms of TRAIL resistance as well as identifying strategies to overcome this problem for an effective therapeutic response remains the cornerstone of many research endeavors. This review aims at presenting an overview of the biology, function and translational relevance of TRAIL with a specific view to discussing the various regulatory mechanisms and the current trends in reverting TRAIL resistance of cancer cells with the obvious implication of an improved clinical outcome. © 2009 Elsevier Ltd. All rights reserved.
Source Title: Molecular Aspects of Medicine
URI: http://scholarbank.nus.edu.sg/handle/10635/25192
ISSN: 00982997
DOI: 10.1016/j.mam.2009.12.002
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

80
checked on Dec 6, 2017

WEB OF SCIENCETM
Citations

75
checked on Nov 21, 2017

Page view(s)

206
checked on Dec 10, 2017

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.